CYGEN REFRAMING HEALTHCARE

PROBLEM & MARKET OPPORTUNITY

Patients living in rural areas are

disproportionately more likely to struggle to
access their clinician than a patient living in an
urban or suburban area. The World Health
Organisation stipulates a minimum ratio of
one doctor to 1000 citizens. However, in India
there is only 1:1700. Remote geographic
location, small size, limited workforce,
physician shortages and often constrained
financial resources pose a unique set of

challenges for rural hospitals

© 2023 CYGEN and/or its affiliates. All rights reserved.

PROBLEM & MARKET OPPORTUNITY

Preference of private doctors and clinics over government and private hospitals both
among urban and rural populations.

© 2023 CYGEN and/or its affiliates. All rights reserved.

CYGEN: The Next Big
Thing Enroute towards the #1 Platform,
“The Next Big Thing: The Game Changer”

We are a Multinational Company based out of India & Malaysia. Supported by

partners, including 2 global technology company. We have developed our
Software (own IP) & are powered by AWS. CYGEN provides application focused, patient-centric,
AWARDS & ACHIEVEMENTS innovative, cutting edge technological solutions to
1. Top100 Echelon Summit Asia - Singapore
healthcare problems.
2. Top 15 Women Entrepreneurs –India
Given the gap in health care access and delivery
3. Top100 Biz Award – Malaysia
4. ELECRAMA Grand Jury Award Winner – Impact
system and considering the growing importance and
Award For CYGEN (India) urgency to resolve them, CYGEN group has created a
5. Global Digital Health Company of the cloud based, patient-centric, innovative, cognitive
predictive & preventive healthcare platform.
Year 2019 (India)
6. Thought Leader of the Year – Indian
Govt
7. BIRAC-TiE Winner Award for Women
Entrepreneurial Research – 2020 (india)
8. Digital Health Innovation Winner 2021 (Malaysia)
9. Startup of the Year Award in Healthcare 2021, Meity,
NASSCOM & UN – for Women

© 2023 CYGEN and/or its affiliates. All rights reserved.

OUR SOLUTION

Detailed electronic health record is

HMS, maintained in a downloadable and
PHR,EHR printable form

Risk assessment and predictive scores

Risk derived from the personal data and
Assessment health parameters

Preventive solution which are personalized

Personalized for each individual keeping in mind their
Healthcare unique needs and affordability

Minimizes risk and maximizes coverage

Health for both the provider and customer by
Analysis easy identification of best suited policies

With the help of connected devices and

Remote monitoring cloud computing multiple problems are
solved practically

© 2023 CYGEN and/or its affiliates. All rights reserved.

USP

© 2023 CYGEN and/or its affiliates. All rights reserved.

CYGEN’s COMPETITIVE ANALYSIS
FEATURES

Ø AI based risk prediction & prevention

Ø Real-time monitoring – IoT Devices
Ø 15 minutes TAT for basic screening
Ø Drill-down into single and multi-patient level views
Ø Trending to help address outlined issues
Ø 360 degree management of particulardisease including COVID-19
Ø Configurable timeline view of patientdata
Ø Patients Health Records (PHR), EHRs, Remote monitoring & Virtual Consultation

BENEFITS

Ø Enhanced clinical workflows

Ø Identification of patients for better individual and public management
Ø Prioritization of care
Ø Visualization of key population trends
Ø Improved utilization of management
Ø More timely interventions
Ø Immediate referrals to Doctors – virtually or booking appointments

© 2023 CYGEN and/or its affiliates. All rights reserved.

COMPETITORS
Our holistic approach to healthcare delivery system, commitment to
technological progress and unique approach to market through our valued
partners (B2B), B2C & B2G gives us the competitive advantage

BOOKDOC mFine HealthPlix

Aggregator Aggregator Aggregator
Booking Appointment Doctors & Labs Doctors
Virtual Consultation Referrals Self Test Consultation EMR
with Doctors Reports within 48
hours

© 2023 CYGEN and/or its affiliates. All rights reserved.

SCOPE
To set up healthcare mobile monitoring units that will improve
access to health care services

via state of the art technology.

• Target South India:
ü Direct – 400 E-clinics
ü Indirect – Franchise for Doctors
ü B2G by setting up at Taluk, PHCs & Sub-Centers. Urban and surrounding cities
through
ü Corporates & Societies.

• Resource Requirement:
Each Centers will be staffed with one Phlebotomist / nurse and Marketing. Doctors
based on appointment, and Pharma products

TAT (Turnaround Time) – within 15 mins complete test report can be processed
© 2023 CYGEN and/or its affiliates. All rights reserved.
MILESTONE 1 – 2 mil USD
3-4 months
Ø Increase the infrastructure of the existing lab in Telangana
Ø Open 50 e-clinics / collection centers
Ø Site selection and set up including mobile labs along with home collection
Ø Hire employee and train them
Ø Purchase machines, inventory and supplies
Ø Marketing designing and deployment
Ø Media announcement & PR campaigns
Ø Targeted ad campaigns
Ø Brand awareness ad campaigns
Ø Customer and Competitor analysis
Ø Bundling of different packages

© 2023 CYGEN and/or its affiliates. All rights reserved.

MILESTONE 2 – 8 mil USD
9-12 months
q Upgrade the existing lab to a Hub status in Telangana
q 50 more e-clinics in Telangana
q 50 e-clinics in AP
q 4 satellite centers in Telangana and 2 in AP
q Hub and spoke model

Ø Grand Launch & Press announcement

Ø Corporate and mainstream seminars
Ø Aggressive market campaign
Ø Sales and networking exercise
Ø Capture housing societies, corporates strength
Ø Focus on membership, packages and door to door services

© 2023 CYGEN and/or its affiliates. All rights reserved.

Cont.
Ø Brand reinforcement
Ø Expand market reach to new corporates with follow up of old ones.
Ø Client and end customer feedback review
Ø Capture communities, large housing societies and corporates.
Ø Internal quality service check
Ø Enhancement of service feature both online and offline taking
feedbacks into account
Ø Enhance the customer care services

© 2023 CYGEN and/or its affiliates. All rights reserved.

MILESTONE 3 – 15 mil USD
12-18months
q 1 Hub each in Andhra Pradesh (AP), Karnataka and Tamil
Nadu (TN)
q 2 satellite centers in AP & 4 satellite centres each in Karnataka
and TN
q 50 e-clinics in AP & 100 e-clinics each in Karnataka and TN

Ø R&D review and upgradation according to current and future trend

requirements
Ø Sales and marketing booster training for underperforming team members
Ø Actual customer and Competitor analysis
Ø Bundling of different packages

© 2023 CYGEN and/or its affiliates. All rights reserved.

Cont.
Ø Ramp down old marketing campaigns
Ø Internal audit and review
Ø Technical review and planning
Ø Medical tools and devices upgradation and servicing
Ø Open debate with team members from different divisions of CYGEN,
selected client and customers and advisors for product and service
improvement.
Ø Reward and Recognition of employees – Commissions for sales
personnel
Ø Revise the Business Plan and Marketing strategy
Ø Software enhancement - AI and bug fixing

© 2023 CYGEN and/or its affiliates. All rights reserved.

FUNDS REQUIRED

1. For scaling, investment is required for CYGEN HEALTHCARE AND RESEARCH

LABORATORIES PVT LTD (CHRL). CHRL requires 25 mil USD in stages . To
succeed and minimize the risk of the investment we will scale up in staggered
manner starting with smaller number of centers and expand further after
meeting KPI measures. Accordingly fund will be called in at appropriate stages.

2. Mode of funding agreement and investor interest is to be determined after

further discussion.

As investment comes in, we would scale faster in terms of our market coverage
which will provide employment opportunities and accessible quality healthcare to
the public.

© 2023 CYGEN and/or its affiliates. All rights reserved.

LIQUIDITY & EXIT STRATEGY
Ø We’re confident that with our strong medical and technical background and
well planned-out growth strategies, we’ll be able to generate an ROI of 3-5
times in the next 3 to 5 years for the investors.

Ø We’ll be raising further rounds of investment for Pan India and global
expansions thereafter.

Ø We’re looking for long term investors who can participate in further rounds of
funding too, with in-depth industry knowledge and who’ll be door openers for
CYGEN and partners for growth.

© 2023 CYGEN and/or its affiliates. All rights reserved.

PROJECTION

GROWTH PROJECTION
12,000,000,000.00
10,906,554,355.60
10,000,000,000.00

8,000,000,000.00

6,000,000,000.00

4,000,000,000.00
2,477,221,531.28
2,000,000,000.00
34,975,224.08 531,028,204.68
32,977,823.60
-
Total Total Total Total

© 2023 CYGEN and/or its affiliates. All rights reserved.

Particulars FY23-24 FY24-25 FY25-26 FY26-27 FY27-28

Diagonostic Report Rate (Rs.) 200 249 249 299 399

No. of Sample Collection Centres 600 1,450 1,975 3,350 4,550

No. of Reports Delivered per Sample collection Centre
per day 420 600 900 1,200 2,400

No. of Days in the month 366 365 365 365 366

Revenue from Sample Collection Centres 128,050,000 561,930,750 1,139,610,750 3,088,969,000 11,139,302,748

No. of Satellite Centres 24 24 24 24 24

No.of Reports Delivered per satellite centre per day 900 900 1,200 2,400 2,755

Revenue from Satellite Centres 10,980,000 13,632,750 18,177,000 43,654,000 67,052,748

Central Processing Unit 10,980,000 22,721,250 27,265,500 21,900,000 21,960,000

Revenue

Sale from Lab Testing 150,010,000 584,652,000 1,166,876,250 3,110,869,000 11,161,262,748

TOTAL 150,010,000 584,652,000 1,166,876,250 3,110,869,000 11,161,262,748

Gross Profit 99,061,602 353,821,632 671,272,968 2,194,075,031 8,758,701,101

Total OPEX 117,032,176 340,162,450 660,810,769 1,164,675,673 2,731,929,924

Earnings before Interest, Depreciation and Taxes

(EBITA) 32,977,824 244,489,550 506,065,481 1,946,193,327 8,429,332,824

Interest -

Income Tax 9,893,347 17,778,930 17,778,930 583,857,998 2,528,799,847

Earnings After Interest and Taxes (EAITA) 23,084,477 226,710,620 488,286,551 1,362,335,329 5,900,532,977

Net Worth 32,977,824 34,975,224 531,028,205 2,477,221,531 10,906,554,356

© 2023 CYGEN and/or its affiliates. All rights reserved.

CYGEN ORGANIZATION STRUCTURE
CYGEN CONSULTANCY PVT. LTD. (CCPL)
Incorporated on 20/07/2017
HEALTHTECH AND MEDICAL TRADING

Promoters: 1. Dr. L Tanushree Devi – 60%

2. Sumita Palanisamy - 40%

CYGEN HEALTHCARE AND RESEARCH LABORATORIES PVT. LTD. (CHRL)

Incorporated on 26/03/2021
POINT OF CARE AND DIAGNOSTIC LAB WITH PROPRIETARY TECH

Promoters: 1. CYGEN CONSULTANCY PVT. LTD. – 99.9%

2. Sumita Palanisamy - 0.1%

© 2023 CYGEN and/or its affiliates. All rights reserved.

REVENUE MODEL FOR POINT OF CARE CENTERS

ü B2G
ü B2C (Direct, Indirect - Franchise and Corporates)

o Basic Health Check (including lipid & glucose)

o Comprehensive (including Hba1C & ECG12 Lead)

ü Includes Doctors consultation through Video Consultation

& Remote Monitoring for high risk patients & old aged.

© 2023 CYGEN and/or its affiliates. All rights reserved.

 MANAGEMENT TEAM

DR TANUSHREEDEVI LAISHRAM SUMITA PALANISAMY

Co-Founder & CEO Co-Founder & COO
Clinical Cardiologist (India) (Malaysia)
11 years of experience in primary care Backed with 20 years of expertise
as well as corporate healthcare setups. in IT sector in MNCs like IBM,
HP, Accenture, Microsoft,etc.
Driven by passion to
turnaround healthcare with IT
& Tech.

© 2023 CYGEN and/or its affiliates. All rights reserved.

 DR. TANUSHREE DEVI LAISHRAM
Co-Founder & CEO
Clinical Cardiologist

Young & Enterprising Doctor with passion and vision to Revolutionize Healthcare with Technology,
Dr. Tanushree Devi, a 36 year old women entrepreneur from the state of Manipur is the CEO & CoFounder of
CYGEN, A HealthTech Company based out of India and Malaysia at present. She’s a Clinical Cardiologist and
completed her MBBS from Sikkim Manipal Institute of Medical Sciences and holds degree in Post Graduate
Diploma in Clinical Cardiology from Medwin Hospital Hyderabad and Fellowship in Diabetology from Indian
Medical Association.

Served in State government Health department for 10 years before starting the entrepreneurship journey.
Being exposed to both Rural and Corporate settings of healthcare in the country and abroad, she understands
the loopholes and gaps and how technology can be deployed to bridge those gaps, she’s also an advocate of
early adoption of latest technologies in Healthcare.

In current venture, Machine Learning, Big Data & IoT plays a huge role in making the preventive healthcare
cost effective, remotely accessible and personalized. She’s on a mission to change sick-care to healthcare.

She’s an active member of the North East Development Group and a pioneer women entrepreneur in the
region. She’s an avid nature lover and believes in doing more than talking.

© 2023 CYGEN and/or its affiliates. All rights reserved.

 SUMITA PALANISAMY
CO-FOUNDER / COO

21 years of successful experience providing fiscal, strategic and operations leadership in uniquely
challenging situations.

Sumita has worked at Fortune 500 companies in the IT industries – Microsoft, Accenture Consulting, Hewlett-
Packard, IBM and also an Advisor in one of the top Malaysian association working with Government. Sumita has more
than 21 years’ experience, with assignments based in Asia and North America, most recently as Asia Pacific Director
in Microsoft. She has vast experience in providing Technological Advisory, with background in consulting; facilitation
and training to help clients across Asia improve their performance.

Sumita strives to be a responsible global citizen. Having visited a number of countries - she is an active supporter of
several non-profit organizations. Enthusiast in Data Science and strong Technological background, she has taken huge
leap into Healthcare. She believes as the healthcare industry feels increased pressure from the growing doctor deficit,
artificial intelligence (AI) & AR/VR is poised to pick up the slack. The possibilities for its application make healthcare
AI ripe for innovation, piquing her interest in looking to solve one of society's most pressing problems.

Sumita holds an MBA from Nottingham University in UK and a Bachelor Degree in Business from University of Wales
in UK. She is an active speaker at Business Excellence & Transformation conferences, universities, government
agencies, multinational corporations and professional institutions.

She is a very Enterprising, extroverted and customer-focused leader with a natural ability for building new
businesses and forging loyalty with clients, vendors and external business partners. Identifies and capitalizes on
emerging business ventures to propel an organization to the top-tier of its industry.

© 2023 CYGEN and/or its affiliates. All rights reserved.

 KUMAR RAJA GATTAMANENI
CTO

Mr Kumar Raja Gattamaneni in the capacity of an Architect with Philips Healthcare in previous role has
architected solutions that enables robust care in the Oncology department. Prior to this he had a long stint of 15
years in Philips Healthcare on 2 business groups Nuclear Medicine, Radiation Oncology in various capacities as
developer, team lead, Product Owner and Architect. Specialized in Software Architecture, Medical Image
Processing, Software development methodologies (Waterfall, Agile, BDD and TDD), Software automation,
Reliability, Interoperability.

Believes that HealthTech is the medium to reach a vast number of people and make a difference in their lifestyle.
Data being one of the quality parameter which can attribute to the cause, his interests are naturally in the field
of Machine Learning, Data Science and IoT. Active researcher in this area and have few papers and patents to his
credit.

Education background:
1. M.Sfrom Manipal Academy of Higher Education,2013
2. B.Tech in Computer Science and Engineering from SV University College of Engineering, Tirupati 2007

Publications and Patents:

1. Patent on Treatment Plan Evaluation
2. Patent on Integrated Treatment Plannning Workflow Configuration
3. Patent on Model Based Patient Positioning on MRIsystem
4. Publication on A touchless interface for interventional radiology procedures
5. Publication on The Feasibility of MR-OnlyIMRTPlanning for Prostate Anatomy
6. Publication on Performance of SPICEAuto-contouring on Pseudo CT (MRCAT) based on MRIcompared against Real CT

© 2023 CYGEN and/or its affiliates. All rights reserved.

 LIST OF ADVISORS

DR JAYAKUMAR (IIT, MIT Boston)

TECHNOLOGY ADVISOR
Innovator, Entrepreneur, System and Control Engineering, Aviation and Aerospace,
Internet of Things. Abdul Kalam Sir’s ardent fan and 58 Years of age. 22
Years- Signal Processing (Radio, Speech, Audio, etc.)

AMITABH SINHA
FINANCIAL & MARKET GROWTH ADVISOR
Innovator & Entrepreneur Runs a successful company in Mumbai which grew
exponentially into Middle East & USA, & held various Senior Director's role in
Chamber of commerce before leaving to pursue his passion in mentoring
startups and growth companies.

© 2023 CYGEN and/or its affiliates. All rights reserved.

Thank you

© 2023 CYGEN and/or its affiliates. All rights reserved.